Eli Lilly Stock Edges Higher After Announcing Nearly 4 Billion in VaccineRelated Deals Bernstein Expresses Bullish View on American Tower Corporation AMT Tesla Launches Full SelfDriving Supervised in China After Extended Delays Facing Intense Local EV Competition EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Amid Iran Tensions Oil Prices Edge Higher as USIran Peace Talks Progress Slowly Strait of Hormuz Disruption Persists Dropbox Founder Drew Houston to Step Down as CEO Transition to Executive Chairman After 19 Years RDWR Q1 2026 Earnings EPS Misses Estimates Stock Declines 298 ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline DXR Q3 2007 Earnings Earnings Per Share Surges Past Estimates C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution HBM Q1 2026 Earnings EPS Beats Estimates as Stock Rallies Avita Medical RCEL Gains 22 as Shares Test Key Resistance at 481 Monolithic Power Systems MPWR Surges 46 Breaking Past Key Resistance Levels TTM Technologies TTMI Faces Sharp Decline Amid Sector Headwinds Key Support Levels in Focus EastGroup Properties EGP Edges Higher Amid Sector Rotation LogProstyle Inc LGPS Gains Nearly 5 as Shares Approach Key Resistance Coffee Price Surge to 5 Highlights Global Economic Pressures DFDV Q1 2026 Earnings EPS Miss and Stock Decline Reflect Ongoing Development Phase Adamas Trust Preferred Stock ADAMM Edges Higher as FixedtoFloating Rate Structure Attracts Income Seekers Aspire Biopharma Holdings Warrants ASBPW Languish at Penny Level as Support and Resistance Converge Hertz Warrant HTZWW Slides 175 as Resistance Holds Firm United Maritime Corporation USEA Surges 424 Testing Key Resistance After Support Bounce Rezolve AI Warrants RZLVW Edge Higher Key Technical Levels in Focus nVent Electric NVT Holds Steady Near 165 Testing Key Resistance Zone John Hancock Financial Opportunities Fund BTO Edges Lower as Financial Sector Faces Mixed Signals Gain Therapeutics GANX Edges Higher as Biotech Sector Shows Mixed Signals